e8473ca0-6169-4cbf-8799-fc7cf66dd9e1

You may have missed

Carnegie Learning Selects Littera Tutoring Management System to Support High-Dosage Tutoring in Districts Nationwide

Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A

Glycotope and Max Delbrück Center enter into research collaboration to explore combination of GlycoTargets and CAR technology

Novartis radioligand therapy Lutathera® demonstrated statistically significant and clinically meaningful progression-free survival in first line advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Novartis confirms Sandoz Spin-off for October 4, 2023

error: Content is protected !!